Bio-Techne (TECH) EBITDA Margin (2009 - 2026)
Bio-Techne's quarterly EBITDA Margin came in at 14.94% in Q1 2026, up 666.0% year-on-year from 1.95% in Q1 2025, and up 10.37% quarter-over-quarter from 13.54% in Q4 2025.
Bio-Techne has reported EBITDA Margin for 18 years, with the latest figure at 14.94% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 666.0% year-over-year to 14.94%; the trailing twelve-month figure through Mar 2026 stood at 10.3% (down 3.0% YoY), and the FY2025 full-year result was 7.53%, down 592.0% from the prior year.
- EBITDA Margin for Q1 2026 stood at 14.94%, up from 13.54% in the prior quarter.
- The five-year high for EBITDA Margin was 3647.25% in Q3 2022, with the low at 1.42% in Q2 2025.
- Average EBITDA Margin over 5 years is 228.56%, with a median of 14.39% recorded in 2022.
- Year-over-year, EBITDA Margin soared 362293 bps in 2022 and tumbled 363315 bps in 2023.
- Tracing TECH's EBITDA Margin over 5 years: stood at 24.56% in 2022, then slumped by 38 bps to 15.34% in 2023, then tumbled by 80 bps to 3.14% in 2024, then jumped by 331 bps to 13.54% in 2025, then rose by 10 bps to 14.94% in 2026.
- The last three EBITDA Margin figures came in at 14.94% (Q1 2026), 13.54% (Q4 2025), and 11.75% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.43% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.10% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 18.35% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 17.24% |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 14.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.94% |
| Dec 31, 2025 | 13.54% |
| Sep 30, 2025 | 11.75% |
| Jun 30, 2025 | 1.42% |
| Mar 31, 2025 | 8.28% |
| Dec 31, 2024 | 3.14% |
| Sep 30, 2024 | 17.91% |
| Jun 30, 2024 | 12.28% |
| Mar 31, 2024 | 12.33% |
| Dec 31, 2023 | 15.34% |
| Sep 30, 2023 | 14.10% |
| Jun 30, 2023 | 27.54% |
| Mar 31, 2023 | 24.41% |
| Dec 31, 2022 | 24.56% |
| Sep 30, 2022 | 3,647.25% |
| Jun 30, 2022 | 14.39% |
| Mar 31, 2022 | 22.41% |
| Dec 31, 2021 | 31.53% |
| Sep 30, 2021 | 24.32% |
| Jun 30, 2021 | 8.37% |
| Mar 31, 2021 | 18.89% |
| Dec 31, 2020 | 29.06% |
| Sep 30, 2020 | 23.24% |
| Jun 30, 2020 | 37.03% |
| Mar 31, 2020 | 5.82% |
| Dec 31, 2019 | 71.86% |
| Sep 30, 2019 | 3.43% |
| Jun 30, 2019 | 6.56% |
| Mar 31, 2019 | 25.98% |
| Dec 31, 2018 | 2.97% |
| Sep 30, 2018 | 9.98% |
| Jun 30, 2018 | 7.07% |
| Mar 31, 2018 | 37.01% |
| Dec 31, 2017 | 27.11% |
| Sep 30, 2017 | 10.40% |
| Jun 30, 2017 | 28.08% |
| Mar 31, 2017 | 16.73% |
| Dec 31, 2016 | 3.17% |
| Sep 30, 2016 | 19.39% |
| Jun 30, 2016 | 23.51% |
| Mar 31, 2016 | 4.08% |
| Dec 31, 2015 | 23.11% |
| Sep 30, 2015 | -0.28% |
| Jun 30, 2015 | 31.75% |
| Mar 31, 2015 | 6.26% |
| Dec 31, 2014 | 28.33% |
| Sep 30, 2014 | 5.82% |
| Jun 30, 2014 | 27.39% |
| Mar 31, 2014 | 39.44% |
| Dec 31, 2013 | 35.02% |
| Sep 30, 2013 | -1.69% |
| Jun 30, 2013 | 37.91% |
| Mar 31, 2013 | 44.08% |
| Dec 31, 2012 | 31.26% |
| Sep 30, 2012 | 21.37% |
| Jun 30, 2012 | 53.56% |
| Mar 31, 2012 | 71.20% |
| Dec 31, 2011 | 33.66% |
| Sep 30, 2011 | 30.40% |
| Jun 30, 2011 | 54.59% |
| Mar 31, 2011 | 58.66% |
| Dec 31, 2010 | 55.16% |
| Sep 30, 2010 | 56.46% |
| Jun 30, 2010 | -93.90% |
| Mar 31, 2010 | 59.26% |
| Dec 31, 2009 | 55.79% |
| Sep 30, 2009 | 58.92% |